Canada’s Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 6, 2018--The “Canada’s Pharmaceutical Industry - Porter s Five Forces Strategy Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Canadian pharmaceutical industry is one of the most innovative sectors in Canada and is the 10th biggest pharmaceutical market globally. While branded products account for over 75% of Canadian pharmaceutical sales, the rest is made up of prescriptions and generics combined.
The publisher analyzes Canada’s Pharmaceutical Industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in Industrial Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment.
They consist of those forces close to a company that affect its ability to serve its customers and make a profit. A change in any of the forces normally requires a company to re-assess the marketplace.
Key Topics Covered:
A. Executive Summary
B. Introduction to the Industry
C. Porter’s Five Forces Strategy Analysis
E. Glossary of Terms
For more information about this report visit https://www.researchandmarkets.com/research/35h7p2/canadas?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180706005188/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/06/2018 08:45 AM/DISC: 07/06/2018 08:45 AM